
February21,201708:00ET|Source:DelcathSystems,Inc.NEWYORK,Feb.21,2017(GLOBENEWSWIRE)--DelcathSystems,Inc.(NASDAQ:DCTH),aninterventionaloncologycompanyfocusedonthetreatmentofprimaryandmetastaticlivercancers,announcedthataretrospective,multicenterstudydemonstratedthat45.7percentofpatientswithocularmelanomathatmetastasizedtotheliverwhounderwentpercutaneoushepat...